Genicon Sciences, a San Diego company that has developed a light-based technology to detect biological interactions on microarrays, has completed $32 million in a round of private financing.

Genicon plans to use the funding to commercialize its Resonance Light Scattering (RLS) technology, which it plans to package and launch as a product for microarrays in the first quarter of 2002, said Genicon CEO Patrick Mallon.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.